The role of dendritic cell alterations in susceptibility to hospital-acquired infections during critical-illness related immunosuppression

Molecular Immunology

Volumn 68, Issue 2, 2015, Pages 120-123

  Roquilly, Antoine ^a   Villadangos, Jose A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antigen presentation; Critical diseases; Dendritic cells; Infection; Systemic inflammation

Indexed keywords

BIOLOGICAL FACTOR; CYTOKINE; DANGER ASSOCIATED MOLECULAR PATTERN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 10; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PLACEBO; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; BIOLOGICAL MONITORING; BONE MARROW; CELLULAR IMMUNITY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOGENICITY; INFECTION SENSITIVITY; INNATE IMMUNITY; INTENSIVE CARE UNIT; LYMPHOID ORGAN; MALARIA; MICROORGANISM DETECTION; MULTICENTER STUDY (TOPIC); NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; BACTERIAL INFECTION; CROSS INFECTION; DISEASE PREDISPOSITION; GENETICS; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; MICROBIOLOGY; PATHOLOGY; VIROLOGY; VIRUS INFECTION;

ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; BACTERIAL INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 84955645375     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.06.030     Document Type: Article

References (27)

1. Alter, G., Kavanagh, D., Rihn, S., Luteijn, R., Brooks, D., Oldstone, M., van Lunzen, J., Altfeld, M., 2010. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J. Clin. Invest. 120, 1905-1913, http://dx.doi.org/10.1172/JCI40913.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, 1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, In: Presented at the Critical care medicine, pp. 864-874.
3. Asehnoune, K., Seguin, P., Allary, J., Feuillet, F., Lasocki, S., Cook, F., Floch, H., Chabanne, R., Geeraerts, T., Roger, C., Perrigault, P.F., Hanouz, J.L., Lukaszewicz, A.C., Biais, M., Boucheix, P., Dahyot-Fizelier, C., Capdevila, X., Mahe, P.J., Maguet, P.L., Paugam-Burtz, C., Gergaud, S., Plaud, B., Constantin, J.M., Malledant, Y., Flet, L., Sébille, V., Roquilly, A., 2014. Corti-TC study group, hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir. Med. 2, 706-716, http://dx.doi.org/10.1016/S2213-2600(14)70144-4.
4. Bo, L., Wang, F., Zhu, J., Li, J., Deng, X., 2011. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit. Care 15, R58, http://dx.doi.org/10.1186/cc10031.
5. Boomer, J.S., To, K., Chang, K.C., Takasu, O., Osborne, D.F., Walton, A.H., Bricker, T.L., Jarman, S.D., Kreisel, D., Krupnick, A.S., Srivastava, A., Swanson, P.E., Green, J.M., Hotchkiss, R.S., 2011. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306, 2594-2605, http://dx.doi.org/10.1001/jama.2011.1829.
6. Grimaldi, D., Louis, S., Pene, F., Sirgo, G., Rousseau, C., Claessens, Y.E., Vimeux, L., Cariou, A., Mira, J.P., Hosmalin, A., Chiche, J.D., 2011. Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock. Intensive Care Med. 37, 1438-1446, http://dx.doi.org/10.1007/s00134-011-2306-1.
7. Hotchkiss, R.S., Chang, K.C., Swanson, P.E., Tinsley, K.W., Hui, J.J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., Aspiotis, R., Han, Y., Nicholson, D.W., Karl, I.E., 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1, 496-501, http://dx.doi.org/10.1038/82741.
8. Kamath, A.T., Henri, S., Battye, F., Tough, D.F., Shortman, K., 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100, 1734-1741.
9. Kaukonen, K.-M., Bailey, M., Suzuki, S., Pilcher, D., Bellomo, R., 2014. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 311, 1308-1309, http://dx.doi.org/10.1001/jama.2014.2637.
10. Landelle, C., Lepape, A., Voirin, N., Tognet, E., Venet, F., Bohé, J., Vanhems, P., Monneret, G., 2010. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med. 36, 1859-1866, http://dx.doi.org/10.1007/s00134-010-1962-x.
11. Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., Amit, I., 2014. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312-1326, http://dx.doi.org/10.1016/j.cell.2014.11.018.
12. Lukaszewicz, A.C., Grienay, M., Resche-Rigon, M., Pirracchio, R., Faivre, V., Boval, B., Payen, D., 2009. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit. Care Med. 37, 2746-2752, http://dx.doi.org/10.1097/CCM.0b013-3181ab858a.
13. Meisel, C., Schefold, J.C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., Reinke, P., Volk, H.-D., 2009. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 180, 640-648, http://dx.doi.org/10.1164/rccm.200903-0363OC.
14. Merad, M., Sathe, P., Helft, J., Miller, J., Mortha, A., 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604, http://dx.doi.org/10.1146/annurev-immunol-020711-074950.
15. Perona-Wright, G., Mohrs, K., Szaba, F.M., Kummer, L.W., Madan, R., Karp, C.L., Johnson, L.L., Smiley, S.T., Mohrs, M., 2009. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 6, 503-512, http://dx.doi.org/10.1016/j.chom.2009.11.003.
16. Pène, F., Zuber, B., Courtine, E., Rousseau, C., Ouaaz, F., Toubiana, J., Tazi, A., Mira, J.-P., Chiche, J.-D., 2008. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction. J. Immunol. 181, 8513-8520.
17. Pinzon-Charry, A., Woodberry, T., Kienzle, V., McPhun, V., Minigo, G., Lampah, D.A., Kenangalem, E., Engwerda, C., Lopez, J.A., Anstey, N.M., Good, M.F., 2013. Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria. J. Exp. Med. 210, 1635-1646, http://dx.doi.org/10.1084/jem.20121972.
18. Raffray, L., Douchet, I., Augusto, J.-F., Youssef, J., Contin-Bordes, C., Richez, C., Duffau, P., Truchetet, M.-E., Moreau, J.-F., Cazanave, C., Leroux, L., Mourrissoux, G., Camou, F., Clouzeau, B., Jeannin, P., Delneste, Y., Gabinski, C., Guisset, O., Lazaro, E., Blanco, P., 2015. Septic shock sera containing circulating histones induce dendritic cell-regulated necrosis in fatal septic shock patients. Crit. Care Med. 43, e107-e116, http://dx.doi.org/10.1097/CCM.0000000000000879.
19. Roquilly, A., Braudeau, C., Cinotti, R., Dumonte, E., Motreul, R., Josien, R., Asehnoune, K., 2013. Impaired blood dendritic cell numbers and functions after aneurysmal subarachnoid hemorrhage. PLoS One 8, e71639, http://dx.doi.org/10.1371/journal.pone.0071639.
20. Roquilly, A., Broquet, A., Jacqueline, C., Masson, D., Segain, J.P., Braudeau, C., Vourc'h, M., Caillon, J., Altare, F., Josien, R., Retière, C., Villadangos, J., Asehnoune, K., 2014. Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage. Crit. Care Med. 42, e752-e761, http://dx.doi.org/10.1097/CCM.0000000000000658.
21. Roquilly, A., Mahe, P.J., Seguin, P., Guitton, C., Floch, H., Tellier, A.C., Merson, L., Renard, B., Malledant, Y., Flet, L., Sébille, V., Volteau, C., Masson, D., Nguyen, J.M., Lejus, C., Asehnoune, K., 2011. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA 305, 1201-1209, http://dx.doi.org/10.1001/jama.2011.360.
22. Roquilly, A., Marret, E., Abraham, E., Asehnoune, K., 2015. Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. Clin. Infect. Dis. 60, 64-75, http://dx.doi.org/10.1093/cid/ciu740.
23. Spörri, R., Reis-Sousa, C., 2005. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6, 163-170, http://dx.doi.org/10.1038/ni1162.
24. Vega-Ramos, J., Roquilly, A., Zhan, Y., Young, L.J., Mintern, J.D., Villadangos, J.A., 2014. Inflammation conditions mature dendritic cells to retain the capacity to present new antigens but with altered cytokine secretion function. J. Immunol. 193, 3851-3859, http://dx.doi.org/10.4049/jimmunol.1303215.
25. Wilson, N.S., Behrens, G.M.N., Lundie, R.J., Smith, C.M., Waithman, J., Young, L., Forehan, S.P., Mount, A., Steptoe, R.J., Shortman, K.D., de Koning-Ward, T.F., Belz, G.T., Carbone, F.R., Crabb, B.S., Heath, W.R., Villadangos, J.A., 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7, 165-172, http://dx.doi.org/10.1038/ni1300.
26. Young, L.J., Wilson, N.S., Schnorrer, P., Mount, A., Lundie, R.J., La Gruta, N.L., Crabb, B.S., Belz, G.T., Heath, W.R., Villadangos, J.A., 2007. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc. Natl. Acad. Sci. U. S. A. 104, 17753-17758, http://dx.doi.org/10.1073/pnas.0708622104.
27. Zelenay, S., Reis-Sousa, C., 2013. Adaptive immunity after cell death. Trends Immunol. 34, 329-335, http://dx.doi.org/10.1016/j.it.2013.03.005.